NCT06596213Not yet recruiting
Hepatitis Inequalities Study
Overcoming Inequalities in Health to Eliminate Hepatitis - Real-World Evidence from a Territory-Wide Cohort
Source: ClinicalTrials.gov · Last updated 19 Sept 2024 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
Health inequality in liver diseases including age, gender, ethnicity and socioeconomic status has been increasingly recognised and potentially hinder hepatitis elimination. Health inequality has significant impact to evaluate the impact diagnostic and treatment uptake rates of chronic viral hepatitis on risk of hepatocellular carcinoma (HCC), hepatic event and liver-related death in patients with chronic hepatitis B and/or C. To overcome the limitation of small prospective cohort study of limited recruitment period, retrieving information from the Clinical Data Analysis and Reporting System (CDARS) from Hospital Authority (HA) will be one of the best way to answer these questions.
- Status (registry)
- Not yet recruiting
- Study type
- Observational
- Enrollment
- 100000 (estimated)
- First submitted
- 11 Sept 2024
- Start date
- 1 Oct 2024
- Primary completion date
- 31 Dec 2030
- Lead sponsor
- Chinese University of Hong Kong
- Diseases
- Hepatitis B
- NCT number
- NCT06596213
What you commit to
- Study type: Observational
- Planned participants: 100000
- From 1 Oct 2024 to the primary completion date, 31 Dec 2030
- No sites listed in no country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Serious medical illnesses or malignancy with life expectancy \<1 year
Age
- Patients with missing age, gender, ethnicity and socioeconomic status
Other
- (Subgroup analysis for ethnicity and socioeconomic status) Patients with missing ethnicity and socioeconomic status
Who the study is looking for
- Patients will be eligible if they have any of these viral markers (HBeAg / HBsAg / HBV DNA / HCV RNA) and/or any of the following diagnosis codes (ICD-9 070-070.9; 348.3, 349.82, 456, 456.2, 456.8, 567.2, 567.8, 570, 571.2, 571.5, 571.6, 572.2, 572.3, 572.4, 789.5) checked or coded in any public hospitals or clinics from 1 January 2000 to 31 March 2024.
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
This page is information, not medical advice. Discuss any trial with your doctor.